Operable Breast Cancer Stage I-II receiving neo-adjuvant chemotherapy
Showing 1 - 25 of >10,000
TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,
Not yet recruiting
- TNBC - Triple-Negative Breast Cancer
- (no location specified)
May 8, 2023
Profiling to Help Define Need for Neo-Adjuvant Chemotherapy in
Recruiting
- Breast Cancer
- GEP
-
Jette, Brussel, BelgiumUniversitair Ziekenhuis Brussel
Dec 16, 2022
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- mFOLFIRINOX adjuvant chemotherapy
- mFOLFOX6/XELOX adjuvant chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 12, 2023
Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)
Not yet recruiting
- Breast Neoplasms
- Trilaciclib
- +7 more
-
Guangzhou, Gangdong, ChinaSun-yat sen university cancer center
Jul 30, 2023
ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.
Recruiting
- Breast Cancer Female
- +4 more
-
Ho Chi Minh City, Vietnam
- +1 more
Oct 16, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +6 more
- Biopsy
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 6, 2023
Breast Cancer Trial in Chicago (Cyclophosphamide, Methotrexate, Capecitabine)
Recruiting
- Breast Cancer
- Cyclophosphamide
- +2 more
-
Chicago, IllinoisUniversity of Illinois
Oct 18, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +19 more
- Discussion
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
NSCLC Trial in Shanghai (SBRT+LDRT, Toripalimab, Chemotherapy drug)
Recruiting
- NSCLC
- SBRT+LDRT
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Apr 2, 2023
Targeted Axillary Dissection After Neo-adjuvant Chemotherapy
Recruiting
- Breast Cancer
- TAD (Targeted Axillary Dissection)
-
Jette, Brussel, BelgiumUniversitair Ziekenhuis Brussel
Aug 12, 2022
NSCLC Stage II, NSCLC, Stage IIIA Trial in Goyang-si (Erlotinib)
Active, not recruiting
- NSCLC Stage II
- NSCLC, Stage IIIA
-
Goyang-si, Gyeonggi-do, Korea, Republic ofNational Cancer Center
Apr 4, 2022
Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)
Not yet recruiting
- Triple-negative Breast Cancer
- Pembrolizumab 25 mg/ml
- Paclitaxel injection
- (no location specified)
Oct 11, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Suspended
- Anatomic Stage I Breast Cancer AJCC v8
- +23 more
- Short-Term Fasting
- Chemotherapy
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023
Breast Tumors Trial in Mönchengladbach (drug, diagnostic test, procedure)
Active, not recruiting
- Breast Neoplasms
- Perjeta Injectable Product
- +13 more
-
Mönchengladbach, GermanyEvangelisches Krankenhaus Bethesda Mönchengladbach
Oct 4, 2022
HER2-positive Breast Cancer Trial in Kansas City, Overland Park, Lee's Summit (Taxotere, Carboplatin, Herceptin + Pertuzumab,
Recruiting
- HER2-positive Breast Cancer
- Taxotere, Carboplatin, Herceptin + Pertuzumab
- Metformin
-
Kansas City, Kansas
- +5 more
Dec 4, 2021
Breast Cancer Female Trial in Uppsala (Heavy-load resistance training, Control)
Active, not recruiting
- Breast Cancer Female
- Heavy-load resistance training
- Control
-
Uppsala, SwedenUppsala University Hospital
Nov 1, 2022
Gastric Cancer Trial in Shanghai (Serplulimab, Trastuzuma, Chemotherapy)
Recruiting
- Gastric Cancer
- Serplulimab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 27, 2023
Gut Microbiome and Chemotherapy-Induced Nausea in Women
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Biospecimen Collection
- Questionnaire Administration
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 4, 2023
Cancer-related Fatigue, Neutropenia, Malignant Trial in Taiwan (Astragalus polysaccharides 500 mg, Placebo, EC Chemotherapy)
Completed
- Cancer-related Fatigue
- Neutropenia, Malignant
- Astragalus polysaccharides 500 mg
- +2 more
-
Kaohsiung City, Taiwan
- +4 more
Jun 13, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Cyclophosphamide
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 20, 2023
Cancer Colorectal Trial (a multi-locus blood-based assay)
Not yet recruiting
- Cancer Colorectal
- a multi-locus blood-based assay
- (no location specified)
Sep 7, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Pembrolizumab
- +5 more
- (no location specified)
Apr 12, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +21 more
- Transcutaneous Electrical Nerve Stimulation
-
Atlanta, Georgia
- +2 more
Nov 21, 2022